AXA S.A.

SEC CIK: 0000898427
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overview All 13F holders of HRTX Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2022

Holdings of HRTX by AXA S.A., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−265,000−100.0%	Sold out	Holders
Q1 2023	265,000	$400.1K	<0.1%	−12,700−4.6%	Reduced	Holders
Q4 2022	277,700	$694.3K	<0.1%	00.0%	Unchanged	Holders
Q3 2022	277,700	$1.17M	<0.1%	+277,700	New	Holders